Dublin, April 30, 2020 (GLOBE NEWSWIRE) -- The "Epinephrine Auto-Injector Market - Global Outlook and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering. The Global ...
Auvi-Q 0.1mg is the first epinephrine auto-injector specifically designed for the treatment of life-threatening allergic reactions, including anaphylaxis, in infants and small children weighing 16.5 ...
Credit: Shutterstock. This clinical report from the American Academy of Pediatrics is an update on their 2007 clinical report. HealthDay News — All caregivers for children at risk of anaphylaxis ...
Epinephrine auto-injectors are the mainstay of emergency treatment for anaphylactic allergic reactions, but despite many years of widespread use, important questions about them remain unanswered. At ...
Anaphylaxis can cause severe itching, difficulty breathing, fainting, and abdominal pain. These symptoms usually begin about 30 minutes after coming into contact with an allergy trigger. First, call ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback